MYGN
Myriad Genetics Inc
4.50$
+11.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1995 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| -24.2% | -14.5% | -8.2% | -0.4% | 2.1% | 16.4% | 19.9% | 19.5% | 24.3% | 24.7% | 24.2% | 19.6% | 14.5% | 13.3% | 12.2% | 11.6% | 13.0% | 13.0% | 14.0% | 20.4% | 21.2% | 23.5% | 23.8% | 23.6% | 32.0% | 28.6% | 29.8% | 31.4% | 30.1% | 30.1% | |
| 124.2% | 114.5% | 108.2% | 100.4% | 97.9% | 83.6% | 80.1% | 80.5% | 75.7% | 75.3% | 75.8% | 80.4% | 85.5% | 86.7% | 87.8% | 88.4% | 87.0% | 87.0% | 86.0% | 79.6% | 78.8% | 76.5% | 76.2% | 76.4% | 68.0% | 71.4% | 70.2% | 68.6% | 69.9% | 69.9% | |
| 197.0% | 122.4% | 99.1% | 92.9% | 82.6% | 74.9% | 67.4% | 74.0% | 89.5% | 71.9% | 73.3% | 64.1% | 62.7% | 5.5% | 6.0% | 6.9% | 8.6% | 8.8% | 8.7% | 10.4% | 9.5% | 10.2% | 9.5% | 10.1% | 14.5% | 11.9% | 12.6% | 11.8% | 13.5% | 13.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 42.0% | 41.1% | 42.0% | – | – | – | – | 65.4% | 91.1% | 77.9% | 36.5% | 37.7% | 32.9% | 31.1% | |
| 259.1% | 196.7% | 164.2% | 149.4% | 131.9% | 112.7% | 114.8% | 123.0% | 151.0% | 124.8% | 115.7% | 110.8% | 57.8% | 48.0% | 50.5% | 49.1% | 50.6% | 49.8% | 50.7% | 61.1% | 58.0% | 70.5% | 59.8% | 75.5% | 117.3% | 99.0% | 88.5% | 87.8% | 80.4% | 78.2% | |
| -134.8% | -82.2% | -56.0% | -49.0% | -33.9% | -29.1% | -34.7% | -42.5% | -75.3% | -49.4% | -39.9% | -30.4% | 27.6% | 38.7% | 37.2% | 39.2% | 36.4% | 37.2% | 35.3% | 18.6% | 20.7% | 6.0% | 16.4% | 0.9% | -35.0% | -27.6% | -18.2% | -19.2% | -10.5% | -8.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.8% | 0.4% | 1.4% | 1.9% | 1.0% | 0.5% | 0.4% | 0.3% | 1.3% | |
| -89.4% | -60.5% | -42.2% | -39.5% | -25.6% | -14.6% | -25.1% | -37.9% | -71.7% | -48.5% | -33.4% | -22.3% | 33.7% | 41.8% | 38.8% | 39.7% | 37.2% | 38.0% | 35.7% | 18.7% | 21.1% | 5.0% | 16.1% | 0.9% | -50.9% | -8.3% | -20.7% | -34.8% | -14.7% | -47.9% | |
| 89.4% | 60.5% | 42.2% | 39.5% | 25.6% | 1.3% | 0.9% | 0.6% | -3.6% | -0.9% | -6.5% | 22.3% | 0.3% | 0.1% | -3.2% | 14.7% | 14.6% | 14.0% | 13.1% | 7.6% | 5.2% | 2.6% | -1.7% | -0.5% | -10.8% | -4.3% | -4.2% | 0.1% | 0.5% | -3.5% | |
| -89.4% | -60.5% | -42.2% | -39.5% | -25.6% | -15.9% | -26.0% | -38.6% | -71.7% | -48.5% | -33.4% | -22.3% | 21.5% | 25.9% | 42.0% | 25.0% | 22.6% | 24.0% | 22.6% | 11.1% | 15.8% | 2.4% | 17.9% | 0.5% | -40.2% | -3.9% | -16.5% | -35.0% | -15.2% | -44.4% | |
| -110.6% | -65.8% | -41.8% | -36.4% | -24.3% | -20.8% | -26.3% | -34.3% | -65.1% | -42.1% | -33.9% | -25.6% | 31.6% | 41.6% | 39.2% | 41.0% | 38.2% | 38.6% | 37.0% | 22.1% | 24.7% | 12.4% | 23.9% | 10.0% | -22.2% | 1.8% | -12.5% | -26.2% | -7.1% | -40.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.